InKine Pharmaceutical Company, Inc. (INKP) To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference 
10/19/2005 5:12:46 PM

BLUE BELL, Pa.--(BUSINESS WIRE)--Feb. 17, 2005--InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that Mr. Robert Apple, Chief Operating Officer and Chief Financial Officer of InKine, is scheduled to present the Company's strategies and business opportunities on Wednesday, February 23, 2005 at 2:00 p.m. at the BIO CEO & Investor Conference. The conference is being held at the Waldorf Astoria in New York City from February 23 through February 24, 2005.